Cargando…
Translational precision medicine: an industry perspective
In the era of precision medicine, digital technologies and artificial intelligence, drug discovery and development face unprecedented opportunities for product and business model innovation, fundamentally changing the traditional approach of how drugs are discovered, developed and marketed. Critical...
Autores principales: | Hartl, Dominik, de Luca, Valeria, Kostikova, Anna, Laramie, Jason, Kennedy, Scott, Ferrero, Enrico, Siegel, Richard, Fink, Martin, Ahmed, Sohail, Millholland, John, Schuhmacher, Alexander, Hinder, Markus, Piali, Luca, Roth, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179706/ https://www.ncbi.nlm.nih.gov/pubmed/34090480 http://dx.doi.org/10.1186/s12967-021-02910-6 |
Ejemplares similares
-
Changing R&D models in research-based pharmaceutical companies
por: Schuhmacher, Alexander, et al.
Publicado: (2016) -
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
por: Cardner, Mathias, et al.
Publicado: (2023) -
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?
por: Schuhmacher, Alexander, et al.
Publicado: (2018) -
How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective
por: Germann, Paul G, et al.
Publicado: (2013) -
Translating Precision
por: Pacanowski, MA
Publicado: (2017)